Hyperion Therapeutics Lands $13,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=54ada9c7-e0c7-41f9-9c81-20188c2a26ab&Preview=1 -
Date
5/18/2009 -
Company Name
Hyperion Therapeutics -
Mailing Address
601 Gateway Blvd South San Francisco, CA 94080 -
Company Description
Hyperion Therapeutics, Inc. is a privately held specialty biopharmaceutical company dedicated to improving patients’ lives through the development and commercialization of therapies that address critical unmet needs and underserved patient populations. The Company’s initial efforts are focused in the areas of gastroenterology and hepatology. -
Website
http://www.hyperiontx.com -
Transaction Type
Venture Equity -
Transaction Amount
$13,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
